LEXISCAN(R) (REGADENOSON)
NDC 51662-1448, LEXISCAN(R) (REGADENOSON), injection, solution, from HF Acquisition Co LLC, DBA HealthFirst.
- Product NDC
- 51662-1448
- Status
- Listed
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022161
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1448 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- REGADENOSON.08 mg/mL
Pharmacologic classes
Adenosine Receptor Agonists [MoA]; Pharmacologic Cardiac Stress Test Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51662-1448-1 | 51662144801 | 1 SYRINGE, PLASTIC in 1 CARTON (51662-1448-1) / 5 mL in 1 SYRINGE, PLASTIC |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/99640071-4db2-9317-e053-2995a90a610d
Use it
Look up 51662-1448 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1448 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51662-1448. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.